Myo-inositol is a naturally occurring sugar-like compound that your body uses to relay signals between hormones and cells. It belongs to the same chemical family as simple sugars, with the molecular formula C6H12O6, but it behaves more like a vitamin in practice. Your body produces it on its own, and you also get it from food, which is why scientists classify it as a “pseudovitamin”: vital for normal function, but not technically essential through diet because a deficiency alone doesn’t cause a specific disease.
Most people searching for myo-inositol have heard about it in connection with PCOS, fertility, insulin resistance, or anxiety. Here’s what it actually does in the body and what the clinical evidence shows for each of those uses.
How Myo-Inositol Works in the Body
Once myo-inositol enters a cell, it gets converted into a molecule called phosphatidyl-myo-inositol, which then becomes a second messenger, essentially a relay signal that carries instructions from hormones on the outside of a cell to the machinery inside it. Three hormones in particular depend on this relay system: insulin, follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH).
For insulin, this matters because the second messengers that myo-inositol produces have insulin-mimetic activity, meaning they can partially replicate what insulin does. They help cells respond to insulin’s signal to absorb blood sugar. For FSH, the same relay system helps ovarian cells respond to the hormone that triggers egg maturation. This dual role in both blood sugar regulation and reproductive hormone signaling is why myo-inositol keeps showing up in research on metabolic and fertility conditions.
PCOS and Ovulation
Polycystic ovary syndrome is by far the most studied use for myo-inositol supplementation. PCOS often involves insulin resistance, elevated androgen levels, and irregular or absent ovulation, and myo-inositol appears to address several of these at once. Clinical trials show it lowers androgen levels and reduces insulin resistance, which together can help restore ovulatory menstrual cycles, particularly in women with obesity-related PCOS.
The numbers vary across studies. In one randomized trial, 65% of women taking myo-inositol ovulated, and 30% achieved spontaneous pregnancies. Another trial found ovulation rates of 25% with myo-inositol versus 15% with placebo. A meta-analysis of women undergoing fertility treatments found that pre-treatment with myo-inositol increased clinical pregnancy rates from about 28% to 33%, and reduced miscarriage rates by 27%. Another meta-analysis found clinical pregnancy rates doubled: 22% with myo-inositol versus 11% without.
That said, results aren’t universally positive. A Cochrane review, the gold standard for evidence synthesis, was unable to confirm that myo-inositol increases the chance of pregnancy and live birth, largely because the existing studies are small and use different methods. The most consistent finding is that myo-inositol improves oocyte (egg) quality and reduces the amount of fertility medication needed during assisted reproduction. The standard dose used in PCOS trials is 4 grams per day, typically split into two 2-gram doses, taken for at least three months before ovarian stimulation.
Insulin Resistance and Metabolic Health
Because myo-inositol’s second messengers mimic some of insulin’s effects, supplementation can improve how well cells respond to insulin. In a study of women with PCOS and metabolic abnormalities, three months of supplementation with myo-inositol (combined with a small amount of D-chiro-inositol in a 40:1 ratio) significantly reduced both BMI and HOMA-IR, which is the standard clinical measure of insulin resistance. The number of patients with elevated insulin levels also dropped.
This ratio of 40 parts myo-inositol to 1 part D-chiro-inositol mirrors the natural proportion found in the body. D-chiro-inositol is a related compound that handles a different piece of the insulin signaling puzzle. Many supplements now use this 40:1 combination, and the research supporting it comes primarily from PCOS populations. Whether the same metabolic benefits apply broadly to people with insulin resistance who don’t have PCOS is less well established.
Panic Disorder and OCD
Myo-inositol has a separate line of research in mental health, at much higher doses. In a trial of 20 people with panic disorder, those taking 18 grams of inositol daily for one month experienced fewer panic attacks per week than those taking a commonly prescribed anxiety medication. A separate four-week study found that 12 grams per day also reduced the frequency and severity of panic attacks.
For OCD, a small study found that 18 grams daily for six weeks reduced symptoms. The mental health doses (12 to 18 grams per day) are substantially higher than the 4-gram doses used for PCOS and metabolic health, which is worth noting because side effects become more likely at these levels.
Male Fertility
Myo-inositol isn’t only relevant to female reproduction. In a randomized clinical trial of men with low sperm count and poor motility, treatment with myo-inositol significantly improved sperm motility, including progressive motility (the ability of sperm to swim forward effectively). Sperm concentration, however, did not change. The research here is thinner than for PCOS, but the biological rationale is sound: myo-inositol plays a role in the signaling pathways that regulate sperm cell function.
Food Sources
Your body manufactures myo-inositol, primarily in the kidneys, and you also consume it through diet. The richest food sources are fruits, beans, grains, and nuts. Fresh produce contains more myo-inositol than frozen, canned, or processed versions. A typical diet provides somewhere between 225 and 1,500 milligrams per day, depending on food choices. That’s well below the 4,000-milligram therapeutic doses used in clinical trials, which is why supplementation is necessary for the effects seen in research.
Side Effects and Dosing
Myo-inositol is well tolerated at the doses used in most clinical research. A safety review found that only at 12 grams per day did mild gastrointestinal side effects appear: nausea, gas, and diarrhea. Notably, the severity of these effects did not increase as the dose climbed higher, so the discomfort tends to stay mild even at the upper end of therapeutic dosing.
The most common dosing strategies in the research break down by health goal. For PCOS and insulin resistance, 4 grams daily (split into two doses) is standard, often combined with D-chiro-inositol at a 40:1 ratio. For panic disorder and OCD, studies have used 12 to 18 grams daily for four to six weeks. Myo-inositol is available as both a powder (easier to take at high doses) and capsules. The powder dissolves in water and has a mildly sweet taste, which makes sense given its chemical similarity to sugar.